Chemotherapy alone may lead to a PCR negative stem cell harvest in transformed lymphoma refractory to rituximab
Cerny, J.; Slavickova, A.; Krepelova, A.; Trneny, M.; Klener, P.
Haematologica 88(3): Ecr06
2003
ISSN/ISBN: 0390-6078 PMID: 12651284 Document Number: 556722
Document emailed within 1 workday
Related Documents
Naparstek, E. 2005: The role of the anti-CD20 antibody rituximab in hematopoietic stem cell transplantation for non-Hodgkin's lymphoma Current Hematology Reports 4(4): 276-283Aurer, I.; Huić, D.; Zuvić, M.; Sever-Prebilić, M.; Ajduković, R.; Radman, I.; Skare-Librenjak, L.; Ostojić-Kolonić, S.; Labar, B. 2006: 90Y-ibritumomab tiuxetan in patients with follicular lymphoma relapsing or refractory to rituximab Lijecnicki Vjesnik 128(7-8): 224-227
Conlan, M.G.; Haire, W.D.; Kessinger, A.; Armitage, J.O. 1991: Prothrombotic hemostatic abnormalities in patients with refractory malignant lymphoma presenting for autologous stem cell transplantation Bone Marrow Transplantation 7(6): 475-479
Schetelig, J.; Fetscher, S.; Reichle, A.; Berdel, W.E.; Beguin, Y.; Brunet, S.; Caballero, D.; Majolino, I.; Hagberg, H.; Johnsen, H.E.; Kimby, E.; Montserrat, E.; Stewart, D.; Copplestone, A.; Rösler, W.; Pavel, J.; Kingreen, D.; Siegert, W. 2003: Long-term disease-free survival in patients with angioimmunoblastic T-cell lymphoma after high-dose chemotherapy and autologous stem cell transplantation Haematologica 88(11): 1272-1278
Kaminer, L.S.; Williams, S.F.; Beschorner, J.; O'Brien, S.; Golick, J.; Bitran, J.D. 1989: High dose chemotherapy with autologous hematopoietic stem cell support in the treatment of refractory stage IV breast carcinoma Bone Marrow Transplantation 4(4): 359-362
Okamura, K.; Mizutani, K.; Hattori, R.; Gotoh, M.; Ono, Y.; Ohshima, S. 2001: Peripheral blood stem cell harvest for patients with germ cell tumors Hinyokika Kiyo. Acta Urologica Japonica 47(6): 397-403
Endoh, A.; Yagihashi, A.; Asanuma, K.; Moriai, R.; Izawa, A.; Koyanagi, Y.; Sato, T.; Kobayashi, D.; Watanabe, N. 2001: Hematopoietic progenitor cell counts performed by the Sysmex SE-9000 analyzer can guide timing of peripheral blood stem cell harvest Anticancer Research 21(1b): 601-604
Ohsaka, A.; Saito, K.; Mori, S.; Sakamoto, S.; Miura, Y. 1989: Transformed malignant lymphoma from Lennert's lesion is a CD4+ T cell lymphoma: an immunohistochemical study Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 52(1): 63-70
Czuczman, M.S. 1999: CHOP plus rituximab chemoimmunotherapy of indolent B-cell lymphoma Seminars in Oncology 26(5 Suppl 14: 88-96
Zhang, H.-Y.; Guan, Z.-Z.; Wang, B.; Huang, H.-Q.; Xia, Z.-J.; Lin, T.-Y. 2008: Relationship between clinopathological features and outcome of rituximab treatment for diffuse large B-cell lymphoma Zhonghua Zhong Liu Za Zhi 30(5): 381-384
1977: Transformed cell lymphoma Journal of the Tennessee Medical Association 70(5): 330
Tachi, T.; Yasuda, M.; Usui, K.; Umeda, M.; Nagaya, K.; Osawa, T.; Ichihashi, A.; Noguchi, Y.; Goto, H.; Kasahara, S.; Takahashi, T.; Goto, C.; Teramachi, H. 2015: Risk factors for developing infusion reaction after rituximab administration in patients with B-cell non-Hodgkin's lymphoma Die Pharmazie 70(10): 674-677
Angsirisak, N.; Wittayalertpanya, S.; Limpanasithikul, W.; Bunworasate, U.; Owattanapanich, D. 2015: Correlation of FcγRIIIa Polymorphisms to the Response of Rituximab in Thai Patients with Diffuse Large B-Cell Lymphoma Journal of the Medical Association of Thailand 98(12): 1215-1221
Mougi, H.; Shinmyozu, K.; Osame, M. 1997: Determining the optimal time for peripheral blood stem cell harvest by detecting immature cells (immature leukocytes and immature reticulocytes) using two newly developed automatic cell analyzers International Journal of Hematology 66(3): 303-313
Hołowiecki, J.; Giebel, S.; Walewski, J.; Krawczyk-Kuliś, M.łg.; Hellmann, A.; Skotnicki, A.; Dmoszyńska, A.; Romejko, J.; Czyz, J.ła.; Jurczak, W.; Kachel, Łu.; Wojnar, J.; Stella-Hołowiecka, B.; Saduś-Wojciechowska, M.; Sułek, K.; Jedrzejczak, W.ła.; Robak, T.; Mariańska, B.; Szczylik, C.; Warzocha, K. 2003: Autologous hematopoietic stem cell transplantation for the treatment of aggressive non-Hodgkin's lymphoma. the experience of Polish lymphoma research group Polskie Archiwum Medycyny Wewnetrznej 110(2): 863-868
Hołowiecki, J.; Wojnar, J.; Markiewicz, M.; Wacławik, A.; Jagoda, K.; Kamińska, H.; Kachel, L.; Wojciechowska, M.; Kata, D. 1995: Autologous peripheral blood stem and progenitor cells transplantation as a valid treatment approach in recurrent, refractory lymphoma Archivum Immunologiae et Therapiae Experimentalis 43(3-4): 191-194
Manabe, M.; Hayashi, Y.; Yoshii, Y.; Mukai, S.; Sakamoto, E.; Kanashima, H.; Nakao, T.; Hayama, T.; Fukushima, H.; Inoue, T.; Yamane, T.; Teshima, H. 2012: Primary diffuse large B-Cell lymphoma of the prostate presenting with urinary retention and dyschezia for which rituximab-combined CHOP therapy was effective-a case presentation Gan to Kagaku Ryoho. Cancer and ChemoTherapy 39(11): 1733-1735
Goy, A. 2016: Point: The Role of Stem Cell Transplantation in Mantle Cell Lymphoma: Where It Fits in the New Paradigm Oncology 30(12): 1055-8 1060
Gertz, M.A.; Pineda, A.A.; Chen, M.G.; Letendre, L.; Greipp, P.R.; Solberg, L.A.; Witzig, T.E.; Garton, J.P.; Inwards, D.J.; Litzow, M.R. 1995: Refractory and relapsing multiple myeloma treated by blood stem cell transplantation American Journal of the Medical Sciences 309(3): 152-161
Minigo, H.; Vrhovac, R.; Kalac, M.; Jaksić, B. 2009: Autologous stem cell transplantation in patients with relapsed or refractory Hodgkin's disease Acta Medica Croatica: Casopis Hravatske Akademije Medicinskih Znanosti 63(3): 215-217